AIRWAY VISTA
Home > 연구원 활동 > AIRWAY VISTA
Airway Vista는 2008년 3월에 처음 개최된 이후 매년 세계의 선구적 역할을 하는 석학이 참여하여 폐쇄성폐질환에 대한
최신 지견을 발표하고 토론하는 학술의 장이 되고 있습니다.
▶홈페이지 바로가기
1. 목적: 폐쇄성폐질환 최신 지식 교류 및 연구 활성화
대내적 : 의학계 인식 전환
COPD, 중증 천식이 난치병이 아니라 치료 가능한 가역적인 병으로 인식을 전환하기 위해
노력하고 있으며 COPD 및 중증 천식 임상연구 중요성 홍보를 통한 연구 활성화에 앞장서고 있습니다.
대외적 : 아시아권 COPD 공동연구 제안
서구 석학들에게 국내 연구 수준과 결과를 홍보하고 참여한 아시아 석학들에게 공동연구 네트워크를 제안하여
‘폐쇄성폐질환 아시아 네트워크’를 발족시키 되었습니다.
2. 기대효과
난치병으로 알려진 COPD와 천식의 진단 및 치료 등 의학적 지식을 확산, 보급하며 새로운 치료법을 소개하여
전문의학자, 임상의사 및 기타 의료 종사자들에게 COPD와 중증 천식을 치료할 수 있다는 희망을 제시하고 있습니다.
Introduction
The Airway Vista is hosted by the Clinical Research Center for Chronic Obstructive Airway Diseases that has been supported
by the Asan Medical Center, Seoul and by the Ministry of Health & Welfare, South Korea. Since 2008, we have successfully held
the Airway Vista annually which had more than twentyfive speakers and audience of approximately five hundreds.
This academic occasion aims to provide respiratory professionals with new horizons in understanding chronic obstructive airway diseases
COPD and asthma. It is our belief that it assures to be a premier forum for generating thoughtprovoking discussion on pathogenesis
evaluation, imaging, systemic aspects, exacerbation, heterogeneity, and new treatments of the ailment.
Program Overview
March 27 [SAT] | |
09:00-09:05 | Welcome message |
---|---|
09:05-09:10 | Congratulatory Message |
09:10-10:50 | Plenary1 : When Epidemiology and Image Meet Real-world Practice (English) : Yeon-Mok Oh |
09:10-09:35 | Pierre Ernst : Adverse Effect of Bronchodilator Medication in COPD&Asthma |
09:35-10:00 | Pierre Ernst : Pitfalls in observational pharmaco-epidemiology: The example of beta-blockers in COPD |
10:00-10:25 | Eric Hoffman : Differentiation of Severe and Non-Severe Asthma via Quantitative Computed Tomography |
10:25-10:50 | Eric Hoffman : Role of Sildenafil in Lowering Lung Inflammation During Smoking Cessation: A multispectral CT assessment of lung anatomy and perfused blood volume |
10:50-11:00 | Visit Exhibitors |
11:00-12:40 | Plenary 2 : New Area of Personalized Medicine in Airway Diseases (English) : Ki-Suck Jung |
11:00-11:25 | Craig Hersh : New genomic era in Airway Disease: Asthma-COPD Overlap |
11:25-11:50 | Craig Hersh : Omics and the search for Blood Biomarkers in COPD - Clinical Subtypes of COPD |
11:50-12:15 | Monica Kraft : Biomarkers for the phenotypes and endotypes of severe asthma |
12:15-12:40 | Monica Kraft : Microbiome in Mechanisms of Asthma |
12:40-13:40 | Luncheon Session by GSK: Do we know what to consider for optimal COPD treatment : Paul Jones |
13:40-15:20 | Airway Disease Research and Control Programs in Asia (English) : Tae-Bum Kim |
13:40-14:05 | Naoki Hasegawa : Bronchiectasis and Pulmonary NTM in Japan |
14:05-14:30 | Ching-Hsiung Lin : COPD Control Program in Taiwan |
14:30-14:55 | Hui Fang Lim : National Asthma Program-2 in Singapore |
14:55-15:20 | Joon Beom Seo : Recent update in quantitative imaging of airway disease |
15:20-15:30 | Visit Exhibitors |
15:30-16:45 | Molecular pathobiology and treatable traits in airway diseases (English) : Jung-Hyun Chang |
15:30-15:55 | Woo Jin Kim : Environmental influence and epigenetic alterations in COPD |
15:55-16:20 | Ratko Djukanovic : Targeting treatable traits in airway diseases |
16:20-16:45 | Ratko Djukanovic : Molecular fingerprinting in asthma |
March 28 [SUN] | |
09:00-10:40 | Etiology and assessment of COPD beyond cigarette smoking or lung function (English) : Sei-Won Lee |
---|---|
09:00-09:25 | Nadia Hansel : The effects of indoor air pollution on COPD |
09:25-09:50 | Nadia Hansel : Non-tobacco exposures and COPD: Do other exposures add additional risk? |
09:50-10:00 | Visit Exhibitors |
10:00-11:45 | Panel Discussion: Hot Topics on Guidelines in COPD&Asthma (English) |
10:00-10:35 | Chin Kook Rhee : Hot topics on early COPD in COPD guideline |
10:35-11:10 | Yeon-Mok Oh : Roles of dual and triple therapies in COPD management - GOLD 2021 update and more |
11:10-11:45 | Tae-Bum Kim: Current issues on the treatment of mild asthma |
11:45-12:45 | Luncheon Session by Novartis: A new comprehensive approach to address key unmet needs in asthma : Don Banerji |
12:45-14:25 | Basic and Special Management in COPD (Korean) : Kyeong-Cheol Shin |
12:45-13:10 | Bo Young Lee : Smoking and non-smoking COPD: what is common and different? |
13:10-13:35 | Il-Young Jang : Beyond pulmonary function: the importance of sarcopenia and frailty in elderly airway diseases |
13:35-14:00 | Hyun Lee : When bronchiectasis meets airway diseases: what should physician consider? |
14:00-14:25 | Hyeon Hui Kang : Not just daytime: the impact of sleep quality on the COPD management |
14:25-14:35 | Visit Exhibitors |
14:35-16:15 | Principles and Applications in Asthma Management (Korean) : You Sook Cho |
14:35-15:00 | Su Jeong Kim : Anti-inflammatory reliever in asthma management |
15:00-15:25 | Min-Suk Yang : Pharmacological management of non-eosinophilic asthma |
15:25-15:50 | Min Hye Kim : Severe asthma: what are current issues in Korea? |
15:50-16:15 | Chan Sun Park : Updates in biologics for severe asthma |
16:15-16:20 | Closing |
Speaker